Literature DB >> 32645473

Disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria using hydrogen peroxide plasma: Impact on the reutilization of disposable devices.

Gabriela Ibáñez-Cervantes1, Juan Carlos Bravata-Alcántara2, Alan Steve Nájera-Cortés2, Sergio Meneses-Cruz3, Laura Delgado-Balbuena1, Clemente Cruz-Cruz1, Emilio Mariano Durán-Manuel1, Monica Alethia Cureño-Díaz4, Erika Gómez-Zamora5, Sonia Chávez-Ocaña2, Oscar Sosa-Hernández6, Antonio Aguilar-Rojas7, Juan Manuel Bello-López8.   

Abstract

INTRODUCTION: One of the serious consequences of the SARS-CoV-2 pandemic is the shortage of protective equipment for health personnel. N95 masks are considered one of the essential protective equipment in the management of patients with COVID-19. The shortage of N95 masks implies potential health risks for health personnel and significant economic losses for the health institution. The objective of this work was to investigate the disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria by using hydrogen peroxide plasma.
MATERIAL AND METHODS: We examined the disinfection capacity of hydrogen peroxide plasma against the SARS-CoV-2 and 2 members of the ESKAPE bacteria (Acinetobacter baumannii and Staphylococcus aureus) through a study of artificial contamination in situ of N95 masks. Amplification of specific genes by real-time reverse transcription polymerase chain reaction of SARS-CoV-2 and microbiological culture of ESKAPE bacteria was performed before and after the disinfection process.
RESULTS: SARS-CoV-2 was not detected in all assays using 5 different concentrations of the virus, and A baumannii and S aureus were not cultivable with inoculums of 102 to 106 CFU after disinfection tests of N95 masks with hydrogen peroxide plasma.
CONCLUSION: Disinfection of N95 masks by using the hydrogen peroxide plasma technology can be an alternative for their reuse in a shortage situation. Implications for the use of disinfection technologies of N95 masks and the safety of health personnel are discussed.
Copyright © 2020 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Device reuse; Medical security; Protective equipment

Mesh:

Substances:

Year:  2020        PMID: 32645473      PMCID: PMC7336929          DOI: 10.1016/j.ajic.2020.06.216

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


One of the main difficulties worldwide is the insufficient supply of N95 masks for the care of cases arising in hospital units, for example, United States calculated that will need 3.5 billion N95 respirators for health workers during this pandemic, and currently it calculates that it has 1% of the necessary volume. The shortage of protective equipment for the management of patients carrying the COVID-19 infection caused by the SARS-CoV-2 pandemic has generated the need to implement alternatives that allow its reuse.2, 3, 4 The respiratory tract, being the main route of entry for SARS-CoV-2, is considered one of the main critical points that need protection. , To avoid health personnel of being infected, N95 masks are essential in the management of suspected and confirmed patients of SARS-CoV-2 due to their high level of protection as they prevent the virus from spreading through the bioaerosols generated by the patients’ exhalation.7, 8, 9 Therefore, their shortage implies potential risks of contagion between health personnel and patients. In United States, an alarming number of health workers infected with SARS-CoV-2 has been reported, and more than 100 deaths have been reported worldwide, including doctors and nurses. , This marks the importance of providing safety and sufficient supply of protective equipment to health workers. The protection of the respiratory tract of health personnel is a challenge, therefore, to provide safety to health personnel through the use of N95 masks is crucial during the management of COVID-19 patients. In previous works, the effectiveness of disinfection of N95 masks has already been investigated by using diverse methods, including the use of ultraviolet light and vaporized hydrogen peroxide. , , Furthermore, from a microbiological point of view, ESKAPE bacteria (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter cloacae) causing ventilator-associated pneumonia (VAP) are also a potential risk for health personnel, since the intensive care unit is the main hospital area considered a reservoir for this type of bacteria. In a previous study by our working group, it was reported that 2 members of the ESKAPE group (A baumannii and S aureus) are the main causative agents of VAP in the “Hospital Juárez de México” (HJM). Therefore, the study of the effect of disinfection on this type of bacteria also provides valuable information on microbiological safety for health personnel. The objective of this work was to investigate the disinfection of N95 masks artificially contaminated with SARS-CoV-2 and ESKAPE bacteria by using hydrogen peroxide plasma. Implications for the use of disinfection technologies of N95 masks and the safety of health personnel are discussed.

Materials and methods

SARS-CoV-2, bacterial strains and growth conditions

SARS-CoV-2 and bacterial strains were handled under a biosafety level 2 cabinet according to laboratory biosafety with the operator wearing a coverall protective gown. Prior assays of artificial contamination of N95 masks with SARS-CoV-2 and ESKAPE bacteria, genetic characterization of clinical specimen of SARS-CoV-2 were performed as follows. Nasopharyngeal exudate and trap expectoration samples were collected in virus preservation solution (DOUBANG disposable, Biocomma) from a symptomatic patient admitted to the ICU of the “Hospital Juárez de México” to detect SARS-CoV-2 virus by real-time reverse transcription polymerase chain reaction (RT-PCR), according to the Berlin protocol. Briefly, RNA was extracted and purified with a QIAamp viral RNA mini kit (QIAGEN, Hilden, Germany) following the manufacturer's instructions. A multiplex amplification (E, RdRp, and RNAse P genes) was performed by using the WoV19 Kit (Genes2Life, Irapuato Guanajuato, Mexico) in order to confirm the presence of SARS-CoV-2. The specimen identified as SARS-CoV-2 was kept at 8°C for future experiments. In all RT-PCR assays, positive controls provided by the “Instituto de Diagnóstico y Referencia Epidemiológicos” (InDRE-Mexico) for the E, RdRp, and RNAse P genes were used. Bacterial strains used in this study are part of the collection of microbial pathogens of the research unit of the HJM. Strains were previously isolated from patients admitted to the ICU of the HJM and were genetically identified by 16S rRNA gene sequence analysis (Table 1 ).
Table 1

Virus and bacterial strains used in this study

Virus o strainCharacteristicsSource
SARS-CoV-2Coronaviridae family, E+, RdRp+Clinical isolate
Staphylococcus aureusSlime Producing, icaA+/icaD+, mecA+, SCCmec: TypeIIClinical isolate
Acinetobacter baumanniiMDR strain, eflux pump adeABCRS+Clinical isolate
Virus and bacterial strains used in this study

Preparation of SARS-CoV-2

Serial dilutions (1:10, 1:100, 1:1000, and 1:10000) of SARS-CoV-2 virus were performed in viral preservation media. The undiluted clinical sample containing SARS-CoV-2 was also included in the study. In all dilutions, the presence of SARS-CoV-2 was verified by RT-PCR assays as aforementioned.

Preparation of ESKAPE bacterial suspensions

A baumannii and S aureus were streaked on LB-agar and incubated at 37 °C overnight. Strains were inoculated in LB-broth under agitation at 200 rpm at 37 °C for 24 h. The cultures were adjusted to 106 CFU/50 μl by using a Spectrophotometer 3000 SmartSpec flow (BIORAD) at 600 nm and diluted to 102, 103, 104, and 105 CFU/50 μl. In order to confirm the bacterial concentration, cultures were spread onto LB-agar and incubated for the CFU/ml counting (per triplicate). Bacterial suspensions were stored on an ice bed before use.

Artificial contamination of N95 masks with SARS-CoV-2 and ESKAPE bacteria, and disinfection with hydrogen peroxide plasma

All contamination assays were carried out under aseptic conditions in a laminar flow cabinet. Ten N95 3M masks (Model 8210) were divided in 2 groups A (problem) and B (control). Fifty microliters of each dilution of the SARS-CoV-2 and ESKAPE bacteria were inoculated into 1 cm2 area by the outer surface of the N95 masks as shown in Figure 1 . Subsequently, inoculums were incubated at room temperature for 20 min for their total absorption in the N95 mask material. Over time, “group A” N95 masks (problems) were individually placed in 20 cm X 20 cm sterilization bags “Tyvek” (with STERRAD chemical indicator and STERRAD VELOCITY biological indicator) and were hermetically sealed and subjected to disinfection by using hydrogen peroxide plasma as indicated below. Disinfection experiments were carried in a STERRAD 100NX sterilization system (ASP), by using the “standard STERRAD NX” sterilization cycle under 47 minutes to exposure to peroxide hydrogen plasma and according to the manufacturers’ protocols. “Group B” N95 masks (controls) were subjected to recovery of SARS-CoV-2 and ESKAPE bacteria by RT-PCR and bacterial culture, respectively, as follows.
Fig 1

General strategy for artificial contamination of N95 masks with SARS-CoV-2 and ESKAPE bacteria (Acinetobacter baumannii and Staphylococcus aureus) for subsequent disinfection with hydrogen peroxide plasma. (A) Scheme of inoculation points, (B) Artificial contamination and inocula absorption, (C) Mask packaging, (D) Disinfection with hydrogen peroxide plasma, and (E) SARS-CoV-2 detection and ESKAPE bacteria culture “before and after” treatment with hydrogen peroxide plasma.

General strategy for artificial contamination of N95 masks with SARS-CoV-2 and ESKAPE bacteria (Acinetobacter baumannii and Staphylococcus aureus) for subsequent disinfection with hydrogen peroxide plasma. (A) Scheme of inoculation points, (B) Artificial contamination and inocula absorption, (C) Mask packaging, (D) Disinfection with hydrogen peroxide plasma, and (E) SARS-CoV-2 detection and ESKAPE bacteria culture “before and after” treatment with hydrogen peroxide plasma.

Detection of SARS-CoV-2 and surviving ESKAPE bacteria after disinfection with hydrogen peroxide plasma

After disinfection of N95 masks, inoculation areas of N95 masks with SARS-CoV-2 and ESKAPE bacteria were cut out. The virus and ESKAPE bacteria were separately eluted from the N95 masks in viral preservation medium and saline solution, respectively. The first 5 aliquots were subjected to RNA extraction and specific amplification of E, RdRp, and RNAse P genes, and the last 5 aliquots were appropriately diluted, viable count was made by plating in LB-agar. After incubation, colonies (only if there was growth) were counted and reported as CFU, and the average of CFU was compared “before and after” disinfection process. Death bacterial percentage after disinfection at different bacterial concentrations was calculated. Each experiment was conducted by triplicate.

Results

Hydrogen peroxide plasma inhibits the detection of SARS-CoV-2 by RT-PCR in N95 masks artificially contaminated

To examine the disinfectant activity of hydrogen peroxide plasma, 5 different dilutions of SARS-CoV-2 (including not diluted clinical sample) were inoculated on N95 masks in order to simulate the “real” contamination of the N95 masks in health personnel (Fig 1). All dilutions of SARS-CoV-2 were detected by RT-PCR after inoculation in N95 masks, therefore, the possible not detection of SARS-CoV-2 was due to treatment with hydrogen peroxide plasma. We found that hydrogen peroxide plasma inhibited the detection of the SARS-CoV-2 in all virus dilutions by RT-PCR (compared to control) as soon as it was exposed to treatment (Table 2 ).
Table 2

Results of detection of SARS-CoV-2 specimen and ESKAPE bacteria (Acinetobacter baumannii and Staphylococcus aureus) before and after disinfection of N95 masks artificially contaminated

Virus/Strains testedConcentrations tested(cycle threshold/CFU[50 μl])(Before disinfection N95 masks)
After disinfection N95 masks
Relative concentrationPositive control (Concentration in Ct)Detection of SARS-Cov-2*Bacterial death (%)
SARS-CoV-2 specimenUndiluted14.86NegativeNA
1:1018.07NegativeNA
1:10021.10NegativeNA
1:100024.38NegativeNA
1:1000027.87NegativeNA
Acinetobacter baumannii10286NA100
103880NA100
1049030NA100
1059.6 × 104NA100
1069.3 × 105NA100
Staphylococcus aureus102110NA100
103910NA100
1049600NA100
1059.7 × 104NA100
1069.8 × 105NA100

By RT-PCR method.

Plating on TSA agar method.

Not applicable.

Results of detection of SARS-CoV-2 specimen and ESKAPE bacteria (Acinetobacter baumannii and Staphylococcus aureus) before and after disinfection of N95 masks artificially contaminated By RT-PCR method. Plating on TSA agar method. Not applicable. Hydrogen peroxide plasma kills ESKAPE bacteria in N95 masks artificially contaminated. A baumannii and S aureus strains were completely killed on N95 masks after treatment with hydrogen peroxide plasma at the 5 bacterial concentrations tested. Calculations of viability before and after treatment reflected as 100% bacterial death. This observation was confirmed by absence of bacterial growth in all assays of bacterial recovery by bacterial culture on TSA plates (Table 2).

Discussion

According to the recommendations on the mandatory personal protective equipment for the care of patients with suspected and/or confirmed SARS-CoV-2, this must include gloves, a gown, protective glasses, and face masks; however, N95 respirators allow to have a hermetic seal to the skin, conferring greater protection than surgical masks, being relevant for the processes that can generate aerosols. In compliance with the recommendations and protocols regarding infection prevention and control, these types of respirators have to be discarded, since they are considered single-use disposable devices. , Although, the protection devices of health personnel are considered single-use, in critical situations, such as the current pandemic due to the disease COVID-19, it is necessary to implement strategies that allow the reuse of essential protection devices such as N95 masks. Carrying out disinfection and subsequently reusing disposable N95 respirators should only be considered as a strategy in a situation crisis. Due to the aforementioned, this study was conducted in order to demonstrate that the in vitro conditions of artificial contamination of N95 masks and the subsequent application of the hydrogen peroxide plasma have disinfectant effect against SARS-CoV-2 virus and ESKAPE bacteria (A baumannii and S aureus), causal agents of COVID-19 disease and VAP, respectively. Detection tests by RT-PCR (compared to the control) after treatment with hydrogen peroxide plasma showed that the genes used for the detection of SARS-CoV-2 could not be amplified, even though the sensitivity of the technique under our laboratory conditions is 100 copies of SARS-CoV-2 (Fig 2 ).
Fig 2

Amplification curves by RT-PCR of SARS-CoV-2 in artificially contaminated N95 masks. (A) Control “not treated” with hydrogen peroxide plasma and (B) Problem “treated” with hydrogen peroxide plasma.

Amplification curves by RT-PCR of SARS-CoV-2 in artificially contaminated N95 masks. (A) Control “not treated” with hydrogen peroxide plasma and (B) Problem “treated” with hydrogen peroxide plasma. With these results we speculate that due to the mechanism of action of the hydrogen peroxide plasma, genetic material of SARS-CoV-2 virus was significantly damaged, since it could not be detected by RT-PCR. Hydrogen peroxide gas plasma generated in a closed chamber under vacuum are known to produce charged particles, many of which are highly reactive free radicals. These radicals have the ability to disinfect materials due to their interaction with essential components of bacteria, fungi, and viruses, such as essential enzymes, nucleic acids (DNA and RNA) and therefore, avoid their replicative and infectious capacity.16, 17, 18 The strategy of conducting artificial contamination tests with a specimen of clinical origin of SARS-CoV-2, and not with a viral culture, is fully justified. The tests were aimed to achieve, as much as possible, a real situation of contamination by means of bioaerosols. Health personnel are known to be exposed to SARS-CoV-2 contamination during the exhalation of patients with COVID-19. Bioaerosols generated by infected people have been described as the main cause of contagion of SARS-CoV-2, with saliva particles of breathable size from 1 to 10 μm being the main concern. In contrast, the co-infections reported by ESKAPE bacteria causing VAP in patients with COVID-19 in other parts of the world, are an important factor that could promote the acquisition of bacterial infections , and where health personnel could also be affected. Bacterial strains used in this study have genetic characteristics (virulence and antimicrobial resistance factors) that allow them to form mature biofilms on inert surfaces, such as N95 masks (Table 1). The complete elimination of the strains tested in this study, reinforces the mentioning evidence of the direct damage of hydrogen peroxide plasma in vital macromolecules for the replication of pathogens. With the evidence showed in this work, we believe that the use of hydrogen peroxide plasma under standard conditions of treatment of N95 masks, may be an alternative for disinfection and possibly for other protective devices in shortage situations. Additionally, we contribute to the efforts to generate solid research evidence that supports the viability to disinfect used N95 masks, by using a method that preserves the physical characteristics of protection and that avoids the degradation of the materials with which they are made.

Conclusion

Hydrogen peroxide plasma could be considered an option in the disinfection of N95 masks due to its activity.
  11 in total

1.  Incidence and costs of ventilator-associated pneumonia in the adult intensive care unit of a tertiary referral hospital in Mexico.

Authors:  Oscar Sosa-Hernández; Bernadine Matías-Téllez; Abril Estrada-Hernández; Monica Alethia Cureño-Díaz; Juan Manuel Bello-López
Journal:  Am J Infect Control       Date:  2019-04-11       Impact factor: 2.918

2.  Virus disinfection for biotechnology applications: Different effectiveness on surface versus in suspension.

Authors:  Johanna Kindermann; Michael Karbiener; Sandra M Leydold; Simone Knotzer; Jens Modrof; Thomas R Kreil
Journal:  Biologicals       Date:  2020-02-11       Impact factor: 1.856

3.  Case Report: The Importance of Novel Coronavirus Disease (COVID-19) and Coinfection with Other Respiratory Pathogens in the Current Pandemic.

Authors:  Karam Khaddour; Anna Sikora; Nayha Tahir; Daniel Nepomuceno; Tian Huang
Journal:  Am J Trop Med Hyg       Date:  2020-06       Impact factor: 2.345

4.  Disinfection of N95 respirators by ionized hydrogen peroxide during pandemic coronavirus disease 2019 (COVID-19) due to SARS-CoV-2.

Authors:  V C C Cheng; S-C Wong; G S W Kwan; W-T Hui; K-Y Yuen
Journal:  J Hosp Infect       Date:  2020-04-08       Impact factor: 3.926

5.  The COVID-19 epidemic.

Authors:  Thirumalaisamy P Velavan; Christian G Meyer
Journal:  Trop Med Int Health       Date:  2020-02-16       Impact factor: 2.622

6.  Decontamination of face masks with steam for mask reuse in fighting the pandemic COVID-19: Experimental supports.

Authors:  Qing-Xia Ma; Hu Shan; Chuan-Mei Zhang; Hong-Liang Zhang; Gui-Mei Li; Rui-Mei Yang; Ji-Ming Chen
Journal:  J Med Virol       Date:  2020-06-16       Impact factor: 20.693

7.  Ultraviolet germicidal irradiation: Possible method for respirator disinfection to facilitate reuse during the COVID-19 pandemic.

Authors:  Iltefat H Hamzavi; Alexis B Lyons; Indermeet Kohli; Shanthi Narla; Angela Parks-Miller; Joel M Gelfand; Henry W Lim; David M Ozog
Journal:  J Am Acad Dermatol       Date:  2020-04-01       Impact factor: 11.527

8.  COVID-19 and mycoplasma pneumoniae coinfection.

Authors:  Bingwen Eugene Fan; Kian Guan Eric Lim; Vanessa Cui Lian Chong; Stephrene Seok Wei Chan; Kiat Hoe Ong; Ponnudurai Kuperan
Journal:  Am J Hematol       Date:  2020-04-03       Impact factor: 10.047

9.  Viral dynamics in mild and severe cases of COVID-19.

Authors:  Yang Liu; Li-Meng Yan; Lagen Wan; Tian-Xin Xiang; Aiping Le; Jia-Ming Liu; Malik Peiris; Leo L M Poon; Wei Zhang
Journal:  Lancet Infect Dis       Date:  2020-03-19       Impact factor: 25.071

10.  COVID-19 may transmit through aerosol.

Authors:  Juan Wang; Guoqiang Du
Journal:  Ir J Med Sci       Date:  2020-03-24       Impact factor: 1.568

View more
  17 in total

1.  Effect of moist heat reprocessing of N95 respirators on SARS-CoV-2 inactivation and respirator function.

Authors:  Simeon C Daeschler; Niclas Manson; Kariym Joachim; Alex W H Chin; Katelyn Chan; Paul Z Chen; Kiana Tajdaran; Kaveh Mirmoeini; Jennifer J Zhang; Jason T Maynes; Libo Zhang; Michelle Science; Ali Darbandi; Derek Stephens; Frank Gu; Leo L M Poon; Gregory H Borschel
Journal:  CMAJ       Date:  2020-07-30       Impact factor: 8.262

2. 

Authors:  Simeon C Daeschler; Niclas Manson; Kariym Joachim; Alex W H Chin; Katelyn Chan; Paul Z Chen; Kiana Tajdaran; Kaveh Mirmoeini; Jennifer J Zhang; Jason T Maynes; Libo Zhang; Michelle Science; Ali Darbandi; Derek Stephens; Frank Gu; Leo L M Poon; Gregory H Borschel
Journal:  CMAJ       Date:  2020-12-07       Impact factor: 8.262

Review 3.  Technological Scenario for Masks in Patent Database During Covid-19 Pandemic.

Authors:  Tatianny de Araújo Andrade; José Adão Carvalho Nascimento Junior; Anamaria Mendonça Santos; Lysandro Pinto Borges; Lucindo José Quintans-Júnior; Cristiani Isabel Banderó Walker; Luiza Abrahão Frank; Mairim Russo Serafini
Journal:  AAPS PharmSciTech       Date:  2021-02-11       Impact factor: 3.246

Review 4.  Methods to disinfect and decontaminate SARS-CoV-2: a systematic review of in vitro studies.

Authors:  Chun Shing Kwok; Mustafa Dashti; Jacopo Tafuro; Mojtaba Nasiri; Elena-Andra Muntean; Nicholas Wong; Timothy Kemp; George Hills; Christian D Mallen
Journal:  Ther Adv Infect Dis       Date:  2021-03-16

5.  Pulsed Broad-Spectrum UV Light Effectively Inactivates SARS-CoV-2 on Multiple Surfaces and N95 Material.

Authors:  Alexander S Jureka; Caroline G Williams; Christopher F Basler
Journal:  Viruses       Date:  2021-03-11       Impact factor: 5.048

Review 6.  Safety in the practice of decontaminating filtering facepiece respirators: A systematic review.

Authors:  Juliana Rizzo Gnatta; Rafael Queiroz de Souza; Cassiane de Santana Lemos; Ramon Antônio Oliveira; Lisiane Ruchinsque Martins; Giovana Abrahão de Araújo Moriya; Vanessa de Brito Poveda
Journal:  Am J Infect Control       Date:  2020-12-03       Impact factor: 2.918

Review 7.  Decontamination of respirators amid shortages due to SARS-CoV-2.

Authors:  Ravinder Thaper; Brendan Fagen; Jonghwa Oh
Journal:  Photochem Photobiol Sci       Date:  2021-06-12       Impact factor: 4.328

Review 8.  Personal protective equipment preservation strategies in the covid-19 era: A narrative review.

Authors:  Kiran Grant; James E Andruchow; John Conly; Daniel Dongjoo Lee; Laurie Mazurik; Paul Atkinson; Eddy Lang
Journal:  Infect Prev Pract       Date:  2021-05-08

Review 9.  Potential natural polymer-based nanofibres for the development of facemasks in countering viral outbreaks.

Authors:  Vigneshwaran Shanmugam; Karthik Babu; Thomas F Garrison; Antonio J Capezza; Richard T Olsson; Seeram Ramakrishna; Mikael S Hedenqvist; Shuvra Singha; Mattia Bartoli; Mauro Giorcelli; Gabriel Sas; Michael Försth; Oisik Das; Ágoston Restás; Filippo Berto
Journal:  J Appl Polym Sci       Date:  2021-03-09       Impact factor: 3.125

Review 10.  Review of aerosolized hydrogen peroxide, vaporized hydrogen peroxide, and hydrogen peroxide gas plasma in the decontamination of filtering facepiece respirators.

Authors:  Daniel Berger; Gabrielle Gundermann; Anjana Sinha; Morgan Moroi; Neerav Goyal; Anthony Tsai
Journal:  Am J Infect Control       Date:  2021-06-25       Impact factor: 2.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.